Drug profile · INN
evocalcet
ORKEDIA INITIAL APPROVAL
evocalcet (ORKEDIA INITIAL APPROVAL) is a calcium sensing receptor positive allosteric modulator.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — evocalcet
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
evocalcet (ORKEDIA INITIAL APPROVAL) is a calcium sensing receptor positive allosteric modulator.
Key facts
INN evocalcet
Brand ORKEDIA INITIAL APPROVAL
Mechanism Calcium sensing receptor positive allosteric modulator
Target Extracellular calcium-sensing receptor
Mechanism of action
Calcium sensing receptor positive allosteric modulator
Primary target: Extracellular calcium-sensing receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is evocalcet?
evocalcet (ORKEDIA INITIAL APPROVAL) is a calcium sensing receptor positive allosteric modulator.
What is the brand name for evocalcet?
ORKEDIA INITIAL APPROVAL is a marketed brand name for evocalcet. Check FDA Drugs@FDA for the current US label holder and prescribing information.